Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
M., Woodward, M., Zheng, W., Zhou, M., Bansal, N.,
Designed as a proactive option for individuals with elevated A1C or early metabolic concerns
This is actionable information
This was due to them opting for the promotional first-month pricing rather than locking in the ongoing rate If you cancel, they require confirmation
By activating both hormone pathways, it provides enhanced appetite suppression, improved blood sugar control, and more significant weight loss compared to GLP-1-only medications
Phase 2 trial data published in 2023 in the New England Journal of Medicine (Jastreboff et al., NEJM 2023) reported mean weight reductions of up to approximately 24% over 48 weeks in adults with obesity notably higher than results seen with currently approved agents
US$ 24.58
US$ 22.46
US$ 22.36
